leisure time -WSS

leisure time

author：focus 2025-09-03 03:39:43 - browse：4684

Kuldeep Singh Rajput -- health tech coverage from STAT — Kuldeep Singh Rajput has left his role as CEO of Biofourmis. World Economic Forum

A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role.

A Biofourmis spokesperson confirmed Rajput’s departure to STAT on Wednesday, and said that while the company hunts for a new CEO it will be helmed by a committee of executives overseen by new board member Ben Wanamaker, a partner at Biofourmis investor General Atlantic. The Boston-based company was valued at $1.3 billion following a $320 million Series D financing round which closed last summer and brought big names to Biofourmis: CVS Health was an investor, and Omar Ishrak, former CEO of Medtronic, and Sachin Jain, CEO of the SCAN Health Plan joined the board.

Founded in 2015, Biofourmis has been developing a dizzying array of tech-enabled care offerings, including home-based care services for hospitals, clinical trials support for biopharma companies, and a pipeline of software-based interventions for heart failure and other conditions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Reanimated hearts work just as well for transplants, study finds

WSS

Chamber of Commerce, DOJ clash in court over drug prices

Eli Lilly’s Mounjaro succeeds in second weight

Xenotransplantation trials will require adjusting expectations, experts say

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

People with substance use disorder deserve online privacy

leisure time

leisure time

knowledge

Virginia high school admissions case could be legal follow

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

As demand for Covid shots wanes, Moderna seeks its next success

Patients, doctors are clashing about side effects of hormonal birth control

After affirmative action ruling, medical educators look to 'holistic review'

Eli Lilly’s Mounjaro succeeds in second weight

Jerome Adams on the need for new antivirals for Covid

Grad students accuse University of California of wage theft

How one medical school became remarkably diverse

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Wikipedia

Living organ donors deserve priority status for transplants

How the messy conversation about Dolly changed bioethics

Fed up with FDA, ALS advocates consider a take

Altering the blood type of lungs raises potential for universal organs for transplants

How the messy conversation about Dolly changed bioethics

Patients, doctors press FTC to beef up hospital merger scrutiny

leisure time

entertainment

hotspot

Wikipedia